Aims

In the 1990s, a bioactive bone cement (BABC) containing apatite-wollastonite glass-ceramic (AW-GC) powder and bisphenol-a-glycidyl methacrylate resin was developed at our hospital. In 1996, we used BABC to fix the acetabular component in primary total hip arthroplasty (THA) in 20 patients as part of a clinical trial. The purpose of this study was to investigate the long-term results of primary THA using BABC.

One cementless cup which had porous outer surface with Apatite-Wollastonite glass ceramic (AWGC) coating, was revised 13 years after primary THA because of massive osteolysis expanded to medial iliac wall along the screws. While many retrieved studies of hydroxyapatite-coated cup have been reported, there has been no report on the retrieved cup with AWGC coating. The purpose of this study was to describe this rare case in detail, confirm the bone ingrowth to the porous cup, and discuss on the effectiveness of porous surface with AWGC coating.

Poly-L-lactic acid (PLLA) is characterized by its biocompatibility and biodegradability, and is used clinically. In our hospital, we started to use PLLA screws instead of metallic or ceramic screws in the fixation of acetabular bone grafts in total hip arthroplasty (THA) in 1990, because there were concerns about the use of rigid and nonbioabsorble screws, which might contribute to the absorption of the grafted bone and induce metallosis or third-body wear when breakage of the screws occurs. The purpose of this study was to review a series of cemented THA for dysplasia, with structural autograft fixed with PLLA screws. We focused on the survival rate of the acetabular component and radiological change of the grafted bone–socket interface.

This study included 104 consecutive cemented total hip arthroplasties (80 patients) performed between July 1990 and December 1995 in our hospital. All patients were followed over 10 years and reviewed retrospectively. The grafted bone trimmed from the excised femoral head was fixed rigidly with 1 or 2 PLLA screws (cancellous lag screws 6.5 mm in bore diameter and 4.1 mm in grove diameter) (Fixsorb; Takiron Co., Ltd., Osaka, Japan).

X-ray photographs taken just after the primary operation showed an obscure but still visible radiolu-cent region corresponding to the inserted PLLA screws in many cases.

However, X-ray photographs at the final follow-up showed an unclear radiolucent zone at the sites of the PLLA screws, and the osteosclerotic line surrounding the site where the radiolucent zone had been found was confirmed in only 4 cases. Bone union was confirmed radiologically at the grafted site in every case, and there were no cases of early collapse or extravasation of the grafted bone. No positive resorption of the grafted bone was observed in any case. Kaplan–Meier survivorship analysis of socket revision, radiological loosening of the socket, and the appearance of a radiolucent line > 1 mm in the graft–socket interface as the endpoints indicated survival rates of 99%, 97.1%, and 63.5% at 10 years, and 96.6%, 90.2%, and 56.1% at 15 years, respectively.

The results of this study indicated that PLLA screws are safe and useful for the fixation of acetabular bone graft concomitant to cemented THA with a careful rehabilitation program. However, because of concern about the mechanical insufficiency of the PLLA screws for THA with an early weight-bearing rehabilitation program, we have used mechanically stronger and bioabsorbable screws made of forged composites of hydroxyapatite and PLLA since 2003.

We retrospectively reviewed 40 hips in 36 patients who had undergone acetabular reconstruction using a titanium Kerboull-type acetabular reinforcement device with bone allografts between May 2001 and April 2006. Impacted bone allografts were used for the management of American Academy of Orthopaedic Surgeons Type II defects in 17 hips, and bulk bone allografts together with impacted allografts were used for the management of Type III defects in 23 hips. A total of five hips showed radiological failure at a mean follow-up of 6.7 years (4.5 to 9.3), two of which were infected. The mean pre-operative Merle d’Aubigné score was 10 (5 to 15) vs 13.6 (9 to 18) at the latest follow-up. The Kaplan-Meier survival rate at ten years, calculated using radiological failure or revision of the acetabular component for any reason as the endpoint, was 87% (95% confidence interval 76.3 to 97.7). A separate experimental analysis of the mechanical properties of the device and the load-displacement properties of bone grafts showed that a structurally hard allograft resected from femoral heads of patients with osteoarthritis should be preferentially used in any type of defect. If impacted bone allografts were used, a bone graft thickness of < 25 mm was acceptable in Type II defects.

This clinical study indicates that revision total hip replacement using the Kerboull-type acetabular reinforcement device with bone allografts yielded satisfactory mid-term results.

Removal of femoral bone cement is required for preparation of proper implant bed for reimplantation of a new femoral component in revision total hip arthroplasty. Several devices and procedures have been developed for cement removal, including an extracorporal shock-wave lithotripter and YAG laser, as well as a high-powered drill or burr under the control of conventional fluoroscopic images and an intrafemoral endoscopy. Ultrasonic tools are efficient for removal of bone cement with minimal damage to bone. We use a high-powered burr to remove the deep femoral bone cement under the control of conventional fluoroscopic images, although the problem of this procedure is large exposure of X-ray and two dimensional viewing of burr position which can result in perforation in the third plane.

Computer-assisted fluoroscopic navigation system allows the surgeons to provide positional information about surgical instrument to target bones during operations. Two-dimensional image data are obtained using the fluoroscope with a reference frame and stored on a computer workstation. A camera interfaced with the computer then tracks the position of the patient and registered surgical instruments during the procedure. Taking advantage of the real-time guidance of computer-assisted fluoroscopic navigation system, we introduce a valuable technique using computer-assisted fluoroscopic navigation system for performing removal of the cement of the femoral canal in revision cemented total hip arthroplasty.

Kokubo and one of the present authors (T.N) have developed a new technique of bioactive coating using alkaline and heat treatment, which induces the formation of a thin HA layer on the surface of titanium after implantation in the body. This new coating technique is not associated with degradation or separation of the HA coating, because a bone-like apatite layer of 1 μm in width begins to form in the body tissue after implantation.

Chemically and thermally treated titanium possesses bone-bonding ability, which has been confirmed by detachment tests. Bone ingrowth into bioactive titanium continues to increase throughout the 26 weeks of implantation, whereas bone ingrowth into non-treated or HA plasma coating implants tends to decrease between 6 and 12 weeks. These findings suggest the long-term stability and osteoconduction of the bioactive layer of chemically and thermally treated titanium.

We carried out a series of 70 cementless primary total hip arthroplasties using this coating technique on a porous titanium surface, and followed up the patients for a mean period of 4.8 years. There were no instances of loosening or revision, or formation of a reactive line on the porous coating. Although radiography just after surgery showed a gap between the host bone and the socket in 70% of cases, all the gaps disappeared within a year, indicating the good osteoconduction provided by the coating. Alkaline-heat treatment of titanium to provide a HA coating has several advantages over plasma-spraying, including no degeneration or absorption of the HA coating, simplicity of the manufacturing process, and cost effectiveness. In addition, this method allows homogeneous deposition of bone-like apatite within a porous implant.

Although this was a relatively short-term study, treatment that creates a bioactive surface on titanium and titanium alloy implants has considerable promise for clinical application.

We reviewed 44 consecutive revision hip replacements in 38 patients performed using the cement-in-cement technique. All were performed for acetabular loosening in the presence of a well-fixed femoral component. The mean follow-up was 5.1 years (2 to 10.1). Radiological analysis at final follow-up indicated no loosening of the femoral component, except for one case with a continuous radiolucent line in all zones and peri-prosthetic fracture which required further revision. Peri-operative complications included nine proximal femoral fractures (20.4%) and perforation of the proximal femur in one hip. In five hips wiring or fixation with a braided suture was undertaken but no additional augmentation was required. There was an improvement in the mean Japanese Orthopaedic Association score from 55.5 (28 to 81) pre-operatively to 77.8 (40 to 95) at final follow-up (p < 0.001). Revision using a cement-in-cement technique allows increased exposure for acetabular revision and is effective in the medium term. Further follow-up is required to assess the long-term results in the light of in vitro studies which have questioned the quality of the cement-in-cement bond.

A 30-year-old man presented with pain and limitation of movement of the right hip. The symptoms had failed to respond to conservative treatment. Radiographs and CT scans revealed evidence of impingement between the femoral head-neck junction and an abnormally large anterior inferior iliac spine. Resection of the hypertrophic anterior inferior iliac spine was performed which produced full painless restoration of function of the hip.

Hypertrophy of the anterior inferior iliac spine as a cause of femoro-acetabular impingement has not previously been described.

We have developed bioactive bone cements manufactured from bioactive glass-ceramic powder and BIS-GMA resin, which has the bone-bonding ability. In the present clinical trial, this bioactive bone cement was used for fixation of total hip arthroplasty (THA) and the clinical results were investigated

Two types of bioactive bone cements (high- and low- viscosity type cements) were prepared (Nippon Electric Glass Co. Ltd.). Inorganic filler contained 72.0 wt% AW-GC (apatite and wollastonite containing glass-ceramic) and 27.0 wt% SiO2 powder. All surgery was performed at Kyoto University Hospital between February and October 1996. 20primary THA (20 patients) were performed using bioactive bone cement as a clinical trial. The average age of the patients was 58 years. The average follow-up period was 6 years, 9 months. The diagnosis for 18 hips at the operation was osteoarthritis and 2 hips were rheumatoid arthritis. All sockets and one stem were fixed by bioactive cement, and all but one stem were fixed by PMMA cement. In all cases all polyethylene socket and titanium stem were used (14 KC type THA and 8 KMAX type THA). For the femoral head 22 mm diameter alumina head was used in all cases.

If the bone cement is bioactive and shows direct bonding with the bone, wear particles can’t enter the interface and thus prevention of loosening due to bone resorption would be expected. This cement demonstrated satisfactory clinical results, proving to be a promising material for implant fixation.

Zirconia ceramic femoral head has better mechanical properties than those alumina head has. However, it is concerning whether the wear of UHMWPE against zirconia head is as low as that of alumina head. We compared polyethylene wears against 22.225mm alumina and zirconia heads in total hip arthroplasties (THA) occupied in our hospital.

Kobelco hip prostheses (Kobelco, Kobe, Japan) were used. Titanium alloy stem was cement-fixed and all-polyethylene acetabular components were articulated with alumina or zirconia femoral heads. In the cases from February 1996 to December 1998, 96 primary cemented total hip arthroplasties (THA) in 87 patients of osteoarthritis were observed with a minimum follow-up of five years. The clinical results were evaluated using JOA hip score (100 in normal hip). There were 46 hips with alumina heads and mean follow-up of 6.2 years, and 51 hips with zirconiaheads and mean follow-up of 5.2 years. Mean ages at operation were 58 years. For each patient, the initial postoperative and the latest anterior-posterior radiographs of the pelvis were selected. With the custom software Image-Pro Plus version 4.0, linear wear and volumetric wear were measured.

Clinical results of both heads showed no difference. Linear wear rate of alumina is 0.080±0.047mm/year, while it is 0.147±0.069mm/year for zirconia, significantly higher than alumina (p?0.0001). Volumetric wear rate of zirconia (42.499±20.233mm3/year) is also significantly higher than alumina (27.049±17.216mm3/year) (p?0.0001).

The low thermal conductivity of zirconia is thought to cause local high temperature, leading to the phase transformation and lower-temperature aging degeneration (LTAD) of zirconia head surface. In order to solve this problem, alumina-adding zirconia compound ceramics with lower phase transformation were developed. Hip simulator test revealed much lower wear rate of improved zirconia. This will be discussed.

We retrospectively evaluated 42 hips which had undergone acetabular reconstruction using the Kerboull acetabular reinforcement device between September 1994 and December 1998. We used autogenous bone chips from the ilium and ceramic particle morsellised grafts, even in large acetabular bone defects, in the early stages of the study. Thereafter, femoral head allograft was used as bulk graft in patients with large acetabular defects. Ceramic blocks and the patients’ contralateral femoral head were also used as bulk graft. The mean follow-up period was 8.7 years (4.3 to 12).

Survivorship analysis was performed using radiological failure of the acetabular component, irrespective of whether it was revised, or not, as the end-point.

The survival rate of the morsellised graft group (25 hips) and the bulk graft group (17 hips) at ten years was 53% (95% confidence interval (CI) 42.5% to 63.5%) and 82% (95% CI 72.4% to 91.6%), respectively. The mid-term results of revision total hip replacement with the Kerboull device were better when bulk graft was used in any size of bone defect.

We have been using a Charnley type hip prosthesis with an alumina ceramic head. Three sizes of alumina head, 28, 26 and 22mm, were employed and the Ortron 90 Charnley total hip prosthesis was used at the same period. The objective of this study was to compare the survival rate and the wear rate of those four groups. There were 90, 62, 322 and 88 hips in 28, 26, 22mm alumina head and 0rtron 90 head group. Average age at operation was 49.5, 57.8, 58.0 and 60.6, respectively. A 28 mm prosthesis was indicated for relatively young patients. The mean duration of follow-up was 156, 97, 49 and 110 months, respectively. Twenty patients were chosen at random for each of four groups and the linear wear as seen on X-ray film was measured every two years with a computer and scanner.

Results: The average linear wear rate (mm/yr) was 0.179 for the 28mm, 0.112 for the 26mm, 0.115 for the 22mm alumina head and 0.075 for the Ortron 90 head. The difference between the 28mm group and the other three groups was analyzed statistically. The Kaplan-Meier survivorship analysis, with revision for aseptic loosening as the endpoint, showed the survival rate of the 28mm group appeared to be inferior to that of the other three groups.

Discussion: Our study showed that the wear rate of the 28mm alumina group was highest because low grade alumina was used. In addition, the polyethylene socket used for the 28mm group was thinner than that for the other groups. No clinical superiority of ceramics to metal in terms of polyethylene wear can be shown in this study. A randomized prospective study should be carried out to determine whether an alumina ceramic head is clinically superior to a metallic head in terms of polyethylene wear.

We present a case of septic arthritis of the hip caused by Candida albicans in a 24-year-old woman. This is the first report of a Candida infection of the hip in a patient without any predisposing factors. She underwent a two-stage total hip arthroplasty three years after the onset of the infection. An elevated plasma level of β-D-glucan suggested Candida as the infecting organism and the diagnosis might have been made earlier if this test had been undertaken at presentation.

We examined the behaviour of alumina ceramic heads in 156 cemented total hip arthroplasties, at a minimum follow-up of eight years. They were divided into three groups according to the size of the femoral head; 22, 26, and 28 mm. We measured polyethylene wear radiologically using a computer-aided technique. The linear wear rate of polyethylene sockets for the 28 mm heads was high (0.156 mm/year), whereas those for the 22 and 26 mm heads were relatively low (0.090 and 0.098 mm/year, respectively). Moreover, the surface roughness data of retrieved femoral heads clearly showed maintenance of an excellent surface finish of the current alumina. We conclude that the alumina ceramic femoral heads currently used are associated with a reduced rate of polyethylene wear.

The objective of this study was to compare the wear mode of 100 Mrad PE cups run in a hip simulator to retrieved 100 Mrad PE cups, and to evaluate the efficacy of the PE wear model.

15 In-vitro PE cups: 3 each 0,2.5.50,100 and 150 Mrad (9 channel hip simulator, 6.2 million cycle duration, physiological load profile by Paul, 2000N maximum load at 1Hz using 30% bovine serum). 5 Retrieved PE cups: three SOM cups (Mizuho Medical Instrument Co., COP alloy 28 mm head)-0 Mrad after 8 years of clinical use, two 100 Mrad cups after 15 years of clinical use, two T28 PE 2.5 Mrad cups (Zimmer): 18 years and 13 years of clinical use. The cups were examined using a SEM (Philip XL30 FEG) for wear scar locations and PE wear-topography.

Original machine marks were observed in the weight-bearing areas of the highly cross-linked in-vitro PE. No machine marks were observed for the 0 and 2.5 Mrad in-vitro cups and none were seen in any of the retrieved cups. The formation of more nodules and fibrils in the 0Mrad cups compared to the extensivley cross-linked cups (in-vitro and retrieved) was striking. The frequency of occurrence and length of the fibrils and nodules was dependent on the dose of gamma irradiation. More ripples were formed in the 2.5 Mrad and higher cups compared to the non-irradiated cups (in-vitro and retrieved). The in-vitro cups formed more ripples than the retrieved cups. In general, the SEM features for in-vitro Mrad cups appeared similar to those of the retrieved Mrad cups.

The in-vitro Mrad cups accurately reflected the conditions of the artificial joint in living body. Therefore, comparisons of retrieved PE cups with simulator PE cups appeared to be a very powerful research tool.

(2) SEM observation demonstrated far less wear damage in the extensively cross-linked cups than in the non-extensively cross-linked PE. Thus the extensive cross-linked PE cups appeared to be a significant improvement over conventional PE cups in terms of wear resistance.

The results of 278 consecutive primary total hip arthroplasties performed with bone grafting for ace-tabular bone deficiencies were reviewed at an average of 9.0 years (range, 5–23) after surgery. All patients had underlying developmental dysplasia of the hip. For all hips, the grafts used were from the patients’ own resected femoral heads. All but three grafts were screwed to the supero-lateral aspect of the acetabular roof, the exceptions being grafts without internal fixation. Kaplan-Meier survivorship analysis predicted a rate of survival of the acetabular component at 10 years of 97% (95% confidence interval (CI), 94–100%) with revision for aseptic loosening as the endpoint, and of 82% (95% CI, 76–89%), when radiological loosening was used. Trabecular reorientation, as an indicator of graft incorporation, was seen in 89% of the joints between 1.5 and 5 years (mean 3 years), and delayed up to 7 years. Parametric survivorship analysis using the Cox proportional-hazards model indicated that trochanteric non-union, lateral placement of the socket, and delayed trabecular re-orientation of the bone graft, were risk factors for loosening of the acetabular component. Autogenous acetabular bone grafting will be of value for long-term success and has good potential for additional improvement of the results, provided these three risk factors are reduced. In order to promote the trabecular reorientation, we have gradually improved the surgical technique including sizing of bone graft and adaptation technique. By these alterations of the surgical technique, trabecular reorientation of the 51 joints operated after 1993 was completed by 4 years after surgery.

We evaluated the long-term results of a modified Spitzy shelf operation for secondary osteoarthritis in 119 hips with a mean follow-up of 23.8 years. The mean age of the patients at the time of surgery was 25 years. Preoperative osteoarthritic change, the age at operation and shelf height were important factors in determining the outcome. Of the 61 hips in the pre-stage (three) and the initial stage (58) of osteoarthritis, 53 (87%) had good results, compared with only 30 (51%) of 58 hips with advanced osteoarthritis. Of the latter, 72% of those aged less than 25 years had good results compared with only 40% of patients aged over 25 years. The shelf height in the group with good results was significantly lower than in those with poor results. This operation is a safe procedure and indicated for acetabular dysplasia or subluxation of the hip with early osteoarthritic change in patients aged less than 25 years.

Although the technique of autogenous acetabular bone grafting has been widely used to augment containment of the acetabulum in total hip arthroplasty (THA) for developmental dysplasia, the role of this technique in improving long-term results remains controversial.

We present the long-term results of cemented THA with acetabular bone grafting in 112 patients (133 hips) in order to clarify the factors which affect the outcome. The mean follow-up was for 12.3 years (8 to 24). Kaplan-Meier survivorship analysis predicted a rate of survival of the acetabular component at 15 years of 96% (95% confidence interval (CI) 92 to 99) with revision for aseptic loosening as the endpoint, and of 75% (95% CI 65 to 85) when radiological loosening was used. Parametric survivorship analysis using the Cox proportional-hazards model indicated that trochanteric nonunion, lateral placement of the socket, and delayed trabecular reorientation of the bone graft were risk factors for loosening of the acetabular component.

Our findings have shown that autologous acetabular bone grafting is of value for long-term success provided that the risk factors are reduced.

We have developed a new drug delivery system using porous apatite-wollastonite glass ceramic (A-W GC) to treat osteomyelitis. A-W GC (porosity, 70% and 20% to 30%), or porous hydroxyapatite (HA) blocks (porosity 35% to 48%) used as controls, were soaked in mixtures of two antibiotics, isepamicin sulphate (ISP) and cefmetazole (CMZ) under high vacuum.

We evaluated the release concentrations of the antibiotics from the blocks. The bactericidal concentration of ISP from A-W GC was maintained for more than 42 days, but that from HA decreased to below the detection limit after 28 days. The concentrations of CMZ from both materials were lower than those of ISP. An in vivo study using rabbit femora showed that an osseous concentration of ISP was maintained at eight weeks after implantation. Osteoconduction of the A-W GC block was good.

Four patients with infected hip arthroplasties and one with osteomyelitis of the tibia have been treated with the new delivery system with excellent results.

We have developed a bioactive bone cement (BA cement) consisting of Bis-GMA resin and bioactive glass powder. It has high compressive and tensile strengths, a low curing temperature and its bioactivity allows it to bond directly with bone.

We operated on the 18 femora of nine mongrel dogs for intercalary replacement of part of the bone by a metal prosthesis using either PMMA cement or BA cement for fixation. Three dogs were killed at each of 4, 12 and 26 weeks after surgery for the evaluation of fixation strength by a push-out test and for histological examination by Giemsa surface staining and SEM.

Fixation strengths with PMMA cement at 4, 12 and 26 weeks after surgery were 46.8 ± 18.9, 50.0 ± 24.7, and 58.2 ± 28.9 kgf (mean ±SD), respectively. Those with BA cement were 56.8 ± 26.1, 67.2 ± 19.2, and 72.8 ± 22.2 kgf, respectively. Fibrous tissue intervened between bone and PMMA cement but BA cement had bonded directly to bone at 12 and 26 weeks. This suggests that BA cement will be useful in providing long-lasting fixation of implants to bone under weight-bearing conditions.